SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-060603
Filing Date
2024-05-15
Accepted
2024-05-15 17:24:41
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vcnx-20240331.htm   iXBRL 10-Q 1493182
2 EX-4.3 vcnx-ex4_3.htm EX-4.3 26459
3 PDF COURTESY COPY vcnx-ex4_3.pdf EX-4.3 406395
4 EX-4.4 vcnx-ex4_4.htm EX-4.4 26459
5 PDF COURTESY COPY vcnx-ex4_4.pdf EX-4.4 405112
6 EX-4.5 vcnx-ex4_5.htm EX-4.5 26459
7 PDF COURTESY COPY vcnx-ex4_5.pdf EX-4.5 401451
8 EX-31.1 vcnx-ex31_1.htm EX-31.1 21659
9 EX-31.2 vcnx-ex31_2.htm EX-31.2 21626
10 EX-32.1 vcnx-ex32_1.htm EX-32.1 11571
  Complete submission text file 0000950170-24-060603.txt   9041545

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vcnx-20240331.xsd EX-101.SCH 1291455
77 EXTRACTED XBRL INSTANCE DOCUMENT vcnx-20240331_htm.xml XML 1174331
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38624 | Film No.: 24952687
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)